Back
Ares Management Corp. Vs. Lyell Immunopharma, Inc. Industry Stock Comparison
Buy
61
ARES
Ares Management Corp.
Last Price:
$163.24
Seasonality Move:
7.38%
Sell
45
LYEL
Lyell Immunopharma, Inc.
Last Price:
$31.56
Seasonality Move:
-22.7%
Buy
61
Ares Management Corp. (ARES)
is a Buy
Is Ares Management Corp. a Buy, Sell or Hold?
-
The current Ares Management Corp. [ARES] share price is $163.23. The Score for ARES is 61, which is 22% above its historic median score of 50, and infers lower risk than normal.
-
ARES is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
45
Lyell Immunopharma, Inc. (LYEL)
is a Sell
Is Lyell Immunopharma, Inc. a Buy, Sell or Hold?
-
The current Lyell Immunopharma, Inc. [LYEL] share price is $31.59. The Score for LYEL is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.
-
LYEL is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
ARES Stock Price Chart
What is Ares Management Corp.'s stock price today?
-
The Ares Management Corp. share price today is $163.23The current trend is moderately bearish and ARES is experiencing selling pressure, which indicates risk of future bearish movement.
LYEL Stock Price Chart
What is Lyell Immunopharma, Inc.'s stock price today?
-
The Lyell Immunopharma, Inc. share price today is $31.59The current trend is moderately bullish and LYEL is experiencing selling pressure, which indicates risk of future bearish movement.
ARES Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 2.67 | Buy |
| Relative Strength Index (14 RSI): | 47.23 | Sell |
| Chaikin Money Flow: | -1777372 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (158.65 - 173.35) | Sell |
| Bollinger Bands (100): | (149.77 - 179.15) | Sell |
LYEL Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 3.61 | Buy |
| Relative Strength Index (14 RSI): | 54.3 | Buy |
| Chaikin Money Flow: | -97541 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (24.36 - 35.26) | Buy |
| Bollinger Bands (100): | (10.99 - 25.97) | Buy |
ARES Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 167.68 | Sell |
| 20-day SMA: | 168.81 | Sell |
| 50-day SMA: | 157.75 | Buy |
| 200-day SMA: | 163.97 | Sell |
| 8-day EMA: | 167.75 | Sell |
| 20-day EMA: | 166.38 | Sell |
| 50-day EMA: | 162.61 | Buy |
| 200-day EMA: | 163.72 | Sell |
LYEL Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 35.22 | Sell |
| 20-day SMA: | 31.47 | Buy |
| 50-day SMA: | 23.56 | Buy |
| 200-day SMA: | 14.09 | Buy |
| 8-day EMA: | 34.44 | Sell |
| 20-day EMA: | 31.53 | Buy |
| 50-day EMA: | 25.65 | Buy |
| 200-day EMA: | 18.32 | Buy |
Ares Management Corp. Earnings Growth & ARES Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.34 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.46 per share, and an increase next year of $1.34 per share.
Lyell Immunopharma, Inc. Earnings Growth & LYEL Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $3.96 per share, and a decrease next year of $0.00 per share.
Ares Management Corp. Technical Analysis
| Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 23 | Dec 24 | Dec 26 | Dec 29 | Dec 30 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 16 | 17 | 18 | 19 | 22 | 23 | 24 | 26 | 29 | 30 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Lyell Immunopharma, Inc. Technical Analysis
| Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 23 | Dec 24 | Dec 26 | Dec 29 | Dec 30 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 16 | 17 | 18 | 19 | 22 | 23 | 24 | 26 | 29 | 30 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||